Chimeric Therapeutics Ltd has released a press release.
Chimeric receives $1.8 M advance on FY26 R&D tax incentive
Earlier from Chimeric Therapeutics
- Half Year Report and Appendix 4D 31 December 2025
- Portfolio streamlined - return of CHM CLTX to City of Hope
- Funding and EGM update
- Quarterly Activities/Appendix 4C Cash Flow Report